Integrated Annual Report

Overview

The report presents Orion Pharma Limited's 2023-24 consolidated performance, including BDT 10,620.87 million in net revenue and BDT 318.12 million in net profit. It reports 3,160 employees and states that women comprise 43% of Board members. Environmental initiatives include installed solar PV panels, energy-efficient LED lighting, daylight use and waste treatment through an effluent treatment plant and incinerator.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 July 2023 – 30 June 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services